Lab News
Quadrant wins EUA for COVID-19 saliva test
September 24, 2020 -- Quadrant Biosciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its Clarifi COVID-19 test kit.
September 24, 2020 -- Quadrant Biosciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its Clarifi COVID-19 test kit.
United Airlines launches pilot COVID-19 testing program
September 24, 2020 -- United Airlines has announced a pilot COVID-19 testing program for travelers in which customers traveling on United from San Francisco International Airport to Hawaii will have the option of taking a rapid COVID-19 test at the airport or a self-collected, mail-in test ahead of the trip.
September 24, 2020 -- United Airlines has announced a pilot COVID-19 testing program for travelers in which customers traveling on United from San Francisco International Airport to Hawaii will have the option of taking a rapid COVID-19 test at the airport or a self-collected, mail-in test ahead of the trip.
BD seeks FDA OK to use more samples with HPV test
September 23, 2020 -- Becton Dickinson (BD) has asked the U.S. Food and Drug Administration (FDA) to make the ThinPrep Pap Test PreservCyt Solution vial an approved sample for its Onclarity HPV Assay.
September 23, 2020 -- Becton Dickinson (BD) has asked the U.S. Food and Drug Administration (FDA) to make the ThinPrep Pap Test PreservCyt Solution vial an approved sample for its Onclarity HPV Assay.
CMS continues NTAP for T2's bacteria panel in FY 2021
September 23, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) will continue the new technology add-on payment (NTAP) for T2 Biosystems' T2Bacteria panel for fiscal year 2021.
September 23, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) will continue the new technology add-on payment (NTAP) for T2 Biosystems' T2Bacteria panel for fiscal year 2021.
Promega to further develop OncoMate MSI assay
September 22, 2020 -- Promega announced that it plans to further develop its OncoMate microsatellite instability (MSI) assay as a companion diagnostic test for Incyte's anti-PD-1 drug candidate for endometrial cancer, retifanlimab.
September 22, 2020 -- Promega announced that it plans to further develop its OncoMate microsatellite instability (MSI) assay as a companion diagnostic test for Incyte's anti-PD-1 drug candidate for endometrial cancer, retifanlimab.
Holy Grail: Ilumina nabs cancer testing firm in $8B deal
September 21, 2020 -- Illumina has agreed to acquire cancer diagnostics startup Grail for $8 billion in cash and stock. Grail utilizes Illumina's next-generation sequencing (NGS) technology, data science, and machine learning to identify cancer signals in blood samples.
September 21, 2020 -- Illumina has agreed to acquire cancer diagnostics startup Grail for $8 billion in cash and stock. Grail utilizes Illumina's next-generation sequencing (NGS) technology, data science, and machine learning to identify cancer signals in blood samples.
Hoth, GW partner to develop mobile COVID-19 test
September 21, 2020 -- Clinical-stage biopharmaceutical company Hoth Therapeutics and George Washington University (GW) have partnered to create a device that allows health professionals to diagnose COVID-19 with a mobile device.
September 21, 2020 -- Clinical-stage biopharmaceutical company Hoth Therapeutics and George Washington University (GW) have partnered to create a device that allows health professionals to diagnose COVID-19 with a mobile device.
Siemens donates $500K to Testing for America
September 21, 2020 -- Siemens Healthineers and the Siemens Foundation have partnered with Testing for America to donate $500,000 in funding and COVID-19 testing to historically Black colleges and universities across the country.
September 21, 2020 -- Siemens Healthineers and the Siemens Foundation have partnered with Testing for America to donate $500,000 in funding and COVID-19 testing to historically Black colleges and universities across the country.
Rapid point-of-care COVID-19 test shows promise in clinical study
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.
Discuss
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.
Discuss Qiagen closes NeuMoDx deal
September 18, 2020 -- Qiagen has acquired the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular for $248 million in cash. The deal rounds out Qiagen's portfolio of automated molecular testing based on polymerase chain reaction technology.
September 18, 2020 -- Qiagen has acquired the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular for $248 million in cash. The deal rounds out Qiagen's portfolio of automated molecular testing based on polymerase chain reaction technology.
Webinars/Videos
Case Study™
Conferences
MedTech Conference
October 5-7
Online
October 5-7
Online
College of American Pathologists (CAP) Annual Meeting
October 10-14
Online
October 10-14
Online
Northwest Medical Laboratory Symposium
October 15-16
Online
October 15-16
Online
Global Experts Meeting on Frontiers in Toxicology and Pharmacology
October 26-28
Tokyo, Tokyo Japan
October 26-28
Tokyo, Tokyo Japan
Pathology Visions 2020
October 26-29
Online
October 26-29
Online
Connect
Latest Tweets